913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
Release Date:
Show notes at pharmacyjoe.com/episode913. In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.
The post 913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease? appeared first on Pharmacy Joe.
913: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?